The global gene cloning services market is anticipated to have robust growth in the forecast period, 2023-2027. The growth of the market is attributed to the high-end investments by the public and private players for gene synthesis and cloning services and rapid technological advancements in cloning and sub-cloning services. Increased penetration of synergistic services in the market and the rise in prevalence of infectious and chronic diseases are the other two prominent factors that are expected to boost the demand for the global gene cloning services market over the next five years.
Advantages of using Gene Cloning Services Drives the Market Growth
Gene cloning is expected to transform the medical industry and the biological field. The major advantages of using gene cloning services include analyzing the effect of mutation on a particular gene and making proteins with biomedical techniques. Gene cloning is used to develop recombinant versions of the non-functional gene to understand the functioning of the normal gene. Several specialized providers are providing gene cloning services to interested end users. Generally, the end users prefer to outsource these applications, which not only saves time and effort but also provides technical expertise and facilities dedicated to different molecular cloning and subcloning procedures. Gene cloning services the benefits of fast delivery and several options in select markets and vector types. Researchers and biotechnology companies are expected to benefit from the emergence of gene cloning services as they quickly generate the desired constructs with 100% accuracy, which allows focusing the end users on other critical steps for your research. Therefore, with the rapidly developing biomedical field, the demand for the global gene cloning services market is expected to grow at a significant rate over the next five years.
Increased prevalence of Chronic Diseases Favors the Market Growth
There has been a rise in the occurrence of chronic and lifestyle-related disorders due to the adoption of unhealthy eating habits and sedentary lifestyles among consumers. They are spending less time on physical activities, which is deteriorating their health and giving rise to a number of diseases that can harm their health and sometimes even take the lives of an individual. There has been a constant increase in the demand for the development of effective drugs and disease treatment processes. Cloning can be beneficial in the drug discovery and development process. They are used to identify specific genetic variations to target different therapeutic compounds. Gene cloning services can also be used for the development of vaccines as they help researchers and pharmaceutical companies to study detail about genes and identify receptor subtypes. Gene cloning is also used for the creation of insulin or human growth hormones. Also, their use in gene therapy to treat or prevent disease by correcting the underlying genetic problem is influencing the market demand. The various applications of gene cloning in the biomedical field are expected to fuel the global gene cloning services market demand over the next five years.
DOWNLOAD FREE SAMPLE REPORT
Market Segmentation
Market Players
Thermo Fischer Scientific, Inc., Eurofins Scientific SE, Genscript Biotech Corp, Merck KGaA, Takara Bio Inc., Charles River Laboratories International, Inc., Sartorius AG, Cellecta, Inc., Creative Biogene, Inc., Biocompare, Inc. are the major market players operating in the global gene cloning services market.
| Attribute | Details |
| Base Year | 2021 |
| Historic Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · Service Type · Gene Type · Application · End User |
| Regional scope | North America; Asia Pacific; Europe; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Columbia; South Africa; UAE; Saudi Arabia |
| Key companies profiled | Thermo Fischer Scientific, Inc., Eurofins Scientific SE, Genscript Biotech Corp, Merck KGaA, Takara Bio Inc., Charles River Laboratories International, Inc., Sartorius AG, Cellecta, Inc., Creative Biogene, Inc., Biocompare, Inc. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
